Dexco S.A.

BOVESPA:DXCO3 Stock Report

Market Cap: R$5.2b

Dexco Future Growth

Future criteria checks 4/6

Dexco is forecast to grow earnings and revenue by 60.9% and 6.5% per annum respectively. EPS is expected to grow by 62.1% per annum. Return on equity is forecast to be 7.4% in 3 years.

Key information

60.9%

Earnings growth rate

62.05%

EPS growth rate

Forestry earnings growth23.4%
Revenue growth rate6.5%
Future return on equity7.43%
Analyst coverage

Good

Last updated11 May 2026

Recent future growth updates

Recent updates

Narrative Update May 02

DXCO3: Future Stock Split Will Support More Attractive Multiple Repricing Outlook

Analysts have raised their price target on Dexco from approximately R$7.16 to about R$7.28, citing updated assumptions regarding the discount rate, revenue growth, profit margins and future P/E multiples. Valuation Changes Fair Value: R$7.16 to R$7.28, representing a small upward adjustment in the modelled target price range.
Narrative Update Apr 18

DXCO3: Higher Revenue Outlook And Richer Future P/E Will Support Upside

Analysts have raised their valuation of Dexco, increasing the fair value estimate from R$8.70 to R$9.00. The change reflects updated assumptions that include higher revenue growth expectations, a lower discount rate and a richer future P/E multiple, partly offset by a lower projected profit margin.
Narrative Update Apr 04

DXCO3: Future Stock Split Will Support A More Attractive Repricing Outlook

Analysts have slightly adjusted their R$ price target on Dexco, citing updated assumptions that combine a different fair value estimate with changes to revenue growth, profit margin expectations and a higher future P/E multiple. Valuation Changes Fair Value: R$7.22 in the previous model compared with R$7.16 in the updated assumptions.
Narrative Update Mar 21

DXCO3: Planned Stock Split And Margin Outlook Will Support Future Upside

Analysts have kept their R$ fair value estimate for Dexco steady at R$5.36. Updated assumptions reflect a slightly higher discount rate, a marginally lower revenue growth outlook, a modestly stronger profit margin, and a similar future P/E expectation.
Narrative Update Mar 06

DXCO3: Planned Stock Split Will Support Positive Long Term Outlook

Analysts have revised their R$ price target for Dexco slightly, with the change grounded in updated assumptions that include a different discount rate, adjusted revenue growth and profit margin expectations, and a revised future P/E multiple. What's in the News Dexco plans a stock split or significant stock dividend with a 1.12-for-1 ratio, scheduled for December 26, 2025 (Key Developments).
Narrative Update Feb 20

DXCO3: Future Stock Split Will Support A More Attractive Share Repricing

Analysts have trimmed their R$ price target for Dexco, reflecting a slightly lower fair value estimate alongside updated assumptions for the discount rate, revenue growth, profit margin and future P/E. What's in the News Dexco announced a stock split or significant stock dividend with a 1.12-for-1 ratio, scheduled for December 26, 2025 (Key Developments).
Narrative Update Feb 06

DXCO3: Stock Split And Conservative Earnings Profile Will Support Future Upside

Analysts have reduced their fair value estimate for Dexco from about $8.81 to $8.70 per share. This reflects updated assumptions around discount rates, revenue growth, profit margins and future P/E, which collectively indicate a more conservative earnings profile than previously estimated.
Narrative Update Jan 23

DXCO3: Future Split And Revised Assumptions Will Shape Balanced Outlook

Analysts have reduced their fair value estimate for Dexco from US$6.00 to US$5.36, citing updated assumptions for revenue growth, profit margins, the discount rate, and a lower future P/E multiple. What's in the News Dexco has announced a stock split or significant stock dividend with a 1.12 to 1 ratio, scheduled for December 26, 2025 (Key Developments).
Analysis Article Jan 23

Dexco (BVMF:DXCO3) Has A Somewhat Strained Balance Sheet

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Narrative Update Jan 08

DXCO3: Future Margins And Stock Split Plan Will Support Upside

Analysts have adjusted their price target for Dexco, reflecting a fair value change from $9.83 to $8.81. This shift is tied to updated assumptions for revenue growth, profit margins and future P/E expectations.
Analysis Article Dec 25

Dexco S.A. (BVMF:DXCO3) Not Flying Under The Radar

With a price-to-earnings (or "P/E") ratio of 41.1x Dexco S.A. ( BVMF:DXCO3 ) may be sending very bearish signals at the...
Narrative Update Dec 23

DXCO3: Stronger Future Margins And Investor Day May Drive Upside

Analysts have adjusted their price target on Dexco from R$10.00 to roughly R$9.83 per share. This reflects slightly lower revenue growth assumptions, stronger expected profit margins, and a more conservative future valuation multiple.
Analysis Article Nov 13

Earnings Troubles May Signal Larger Issues for Dexco (BVMF:DXCO3) Shareholders

A lackluster earnings announcement from Dexco S.A. ( BVMF:DXCO3 ) last week didn't sink the stock price. We think that...
Analysis Article Oct 06

Does Dexco (BVMF:DXCO3) Have A Healthy Balance Sheet?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Narrative Update Sep 06

Urbanization Trends And Digital Platforms Will Expand Market Reach

With both revenue growth and net profit margin forecasts holding steady, Dexco’s analyst consensus fair value remains unchanged at R$8.00. Valuation Changes Summary of Valuation Changes for Dexco The Consensus Analyst Price Target remained effectively unchanged, at R$8.00.
Analysis Article Mar 21

Dexco's (BVMF:DXCO3) Anemic Earnings Might Be Worse Than You Think

A lackluster earnings announcement from Dexco S.A. ( BVMF:DXCO3 ) last week didn't sink the stock price. Our analysis...
Analysis Article Mar 15

Dexco S.A. Just Missed Earnings - But Analysts Have Updated Their Models

Shareholders might have noticed that Dexco S.A. ( BVMF:DXCO3 ) filed its full-year result this time last week. The...
User avatar
New Narrative Mar 10

New Ceramic Tiles Factory In Botucatu Will Improve Future Operations

Streamlining of operations could enhance focus on core areas, boosting profitability and improving net margins.
Analysis Article Feb 12

Here's Why Dexco (BVMF:DXCO3) Has A Meaningful Debt Burden

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analysis Article Dec 20

Is Dexco S.A. (BVMF:DXCO3) Potentially Undervalued?

While Dexco S.A. ( BVMF:DXCO3 ) might not have the largest market cap around , it saw significant share price movement...
Analysis Article Dec 02

There's Reason For Concern Over Dexco S.A.'s (BVMF:DXCO3) Price

When close to half the companies in Brazil have price-to-earnings ratios (or "P/E's") below 8x, you may consider Dexco...
Analysis Article Oct 26

Is Dexco (BVMF:DXCO3) A Risky Investment?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article Aug 10

Analysts Are Updating Their Dexco S.A. (BVMF:DXCO3) Estimates After Its Second-Quarter Results

Shareholders of Dexco S.A. ( BVMF:DXCO3 ) will be pleased this week, given that the stock price is up 12% to R$8.05...
Analysis Article Aug 08

Why Dexco S.A. (BVMF:DXCO3) Could Be Worth Watching

Dexco S.A. ( BVMF:DXCO3 ), is not the largest company out there, but it saw a decent share price growth of 14% on the...
Analysis Article Jul 19

Returns On Capital At Dexco (BVMF:DXCO3) Have Stalled

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, a...
Analysis Article May 13

Earnings Miss: Dexco S.A. Missed EPS And Analysts Are Revising Their Forecasts

Last week saw the newest quarterly earnings release from Dexco S.A. ( BVMF:DXCO3 ), an important milestone in the...
Analysis Article May 04

Is It Time To Consider Buying Dexco S.A. (BVMF:DXCO3)?

Dexco S.A. ( BVMF:DXCO3 ), is not the largest company out there, but it saw a double-digit share price rise of over 10...
Analysis Article Apr 15

Slowing Rates Of Return At Dexco (BVMF:DXCO3) Leave Little Room For Excitement

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Analysis Article Mar 14

Dexco's (BVMF:DXCO3) Earnings Might Not Be As Promising As They Seem

Shareholders didn't seem to be thrilled with Dexco S.A.'s ( BVMF:DXCO3 ) recent earnings report, despite healthy profit...
Analysis Article Jan 19

Dexco S.A.'s (BVMF:DXCO3) Earnings Are Not Doing Enough For Some Investors

With a price-to-earnings (or "P/E") ratio of 7.5x Dexco S.A. ( BVMF:DXCO3 ) may be sending bullish signals at the...
Analysis Article Jan 04

Dexco (BVMF:DXCO3) Has A Somewhat Strained Balance Sheet

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article Dec 04

At R$7.43, Is Dexco S.A. (BVMF:DXCO3) Worth Looking At Closely?

Dexco S.A. ( BVMF:DXCO3 ), might not be a large cap stock, but it saw a double-digit share price rise of over 10% in...
Analysis Article Oct 08

Returns Are Gaining Momentum At Dexco (BVMF:DXCO3)

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Analysis Article Sep 13

Is Dexco (BVMF:DXCO3) A Risky Investment?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Analysis Article Jun 22

Returns At Dexco (BVMF:DXCO3) Are On The Way Up

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

Earnings and Revenue Growth Forecasts

BOVESPA:DXCO3 - Analysts future estimates and past financials data (BRL Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202810,0385538251,3446
12/31/20279,38548458692911
12/31/20268,7372898629992
12/31/20258,2491-69851N/A
9/30/20258,216111-6952N/A
6/30/20258,327193441,104N/A
3/31/20258,201258-161,240N/A
12/31/20248,235172-641,284N/A
9/30/20248,119337861,482N/A
6/30/20247,649542-61,440N/A
3/31/20247,607602391,352N/A
12/31/20237,383790981,346N/A
9/30/20237,415812-153975N/A
6/30/20237,808668-151993N/A
3/31/20238,068680-456726N/A
12/31/20228,487756-419794N/A
9/30/20228,7571,128151,226N/A
6/30/20228,7731,2291421,227N/A
3/31/20228,5331,7765501,505N/A
12/31/20218,1701,7258511,708N/A
9/30/20217,8131,4468631,585N/A
6/30/20217,4141,3151,3261,930N/A
3/31/20216,4865741,2891,813N/A
12/31/20205,8804541,0201,508N/A
9/30/20205,4724371,0891,536N/A
6/30/20205,0033417401,187N/A
3/31/20205,1014345781,050N/A
12/31/20195,0124066531,108N/A
9/30/20194,789-21N/A744N/A
6/30/20194,993327N/A445N/A
3/31/20195,016425N/A437N/A
12/31/20184,949432N/A383N/A
9/30/20184,789658N/A303N/A
6/30/20184,296365N/A356N/A
3/31/20184,045223N/A340N/A
12/31/20173,991185N/A405N/A
9/30/20173,917125N/A470N/A
6/30/20173,86472N/A346N/A
3/31/20173,96047N/A540N/A
12/31/20163,91024N/A451N/A
9/30/20163,83650N/A400N/A
6/30/20163,91148N/A493N/A
3/31/20163,86385N/A443N/A
12/31/20153,963183N/A574N/A
9/30/20154,048221N/A691N/A
6/30/20154,064275N/A837N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: DXCO3's forecast earnings growth (60.9% per year) is above the savings rate (12.4%).

Earnings vs Market: DXCO3's earnings (60.9% per year) are forecast to grow faster than the BR market (12.6% per year).

High Growth Earnings: DXCO3's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: DXCO3's revenue (6.5% per year) is forecast to grow faster than the BR market (6.4% per year).

High Growth Revenue: DXCO3's revenue (6.5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: DXCO3's Return on Equity is forecast to be low in 3 years time (7.4%).


Discover growth companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/12 01:39
End of Day Share Price 2026/05/11 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Dexco S.A. is covered by 16 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Guilherme RositoBofA Global Research
Rafael BarcellosBradesco S.A. Corretora de Títulos e Valores Mobiliários
Carlos Palhares SequeiraBTG Pactual